SD

Sandra Dunn

DL Del Mar Pharmaceuticals (Bc) Limited: 2 patents #4 of 13Top 35%
DP Delmar Pharmaceuticals: 1 patents #4 of 8Top 50%
📍 Vancouver, CA: #717 of 5,070 inventorsTop 15%
Overall (All Time): #686,357 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Showing 1–7 of 7 patents

Patent #TitleCo-InventorsDate
12378245 Crystalline forms of an RSK inhibitor Richard Winnike, Elaine McPherson, Erik Flahive, Jonathan James Loughrey 2025-08-05
11234955 Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multiforme and medulloblastoma Dennis M. Brown, Jeffrey A. Bacha 2022-02-01
10758530 Carboxamide derivatives useful as rsk inhibitors Aarthi Jayanthan, Jaipal Reddy Nagireddy, Subhash C. Annedi, John H. van Drie, Timothy S. Daynard +1 more 2020-09-01
10201521 Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem and cancer stem cells including glioblastoma multiforme and medulloblastoma Dennis M. Brown, Jeffrey A. Bacha 2019-02-12
10081632 Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-α]pyrazine-2-carboxamides as RSK inhibitors Aarthi Jayanthan, Jaipal Reddy Nagireddy, Subhash C. Annedi, John H. van Drie, Timothy S. Daynard +1 more 2018-09-25
9771366 Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors Aarthi Jayanthan, Jaipal Reddy Nagireddy, Subhash C. Annedi, John H. van Drie, Timothy S. Daynard +1 more 2017-09-26
9687466 Use of dianhydrogalactitol and analogs and derivatives thereof to treat glioblastoma multiforme Jeffrey A. Bacha, Dennis M. Brown, Anne Steinø 2017-06-27